Today: 19 May 2026
Browse Category

TSX:NXE 6 December 2025 - 31 January 2026

Paladin Energy share price dips as uranium jumps above $100 and a big holder exits the 5% line

Paladin Energy share price dips as uranium jumps above $100 and a big holder exits the 5% line

Paladin Energy shares fell 2.1% to A$13.84 Friday as uranium spot prices climbed above $100 a pound after heavy buying by Sprott Physical Uranium Trust. Kopernik Global Investors disclosed it dropped below the 5% substantial holder threshold on Jan. 23. Paladin produced 1.23 million pounds of U3O8 in the December quarter, up 16%, and sold 1.43 million pounds at $71.8 per pound. Interim results are due Feb. 12.
31 January 2026
·····
Denison Mines stock jumps with uranium names as Phoenix approvals come into focus

Denison Mines stock jumps with uranium names as Phoenix approvals come into focus

Denison Mines shares rose about 4.1% to $3.70 Friday morning, trading as high as $3.80, as uranium stocks advanced. Cameco gained 3.8% and Uranium Energy jumped 4.6%. Investors are watching for final approvals on Denison’s Phoenix uranium mine in Canada, which could start construction this year. Around 7.3 million Denison shares changed hands by mid-morning.
16 January 2026
·····
NexGen Energy stock hits a fresh 52-week high as Canada regulator deadline nears

NexGen Energy stock hits a fresh 52-week high as Canada regulator deadline nears

NexGen Energy shares hit a 52-week high of $10.70 before easing to $10.55, up 2.9% in U.S. trading Monday. The move comes ahead of a Jan. 9 deadline for public interventions on the company’s proposed Rook I uranium project. Uranium-linked stocks and the Global X Uranium ETF also climbed. The Canadian Nuclear Safety Commission will hold a second hearing on Rook I in February.
5 January 2026
··
ASX top stocks today: Silex jumps 9% in uranium surge as WiseTech drops on ACCC move

ASX top stocks today: Silex jumps 9% in uranium surge as WiseTech drops on ACCC move

Silex Systems surged 9.43% to A$9.75, leading uranium and rare-earth stocks higher on the ASX 200, which closed nearly flat at 8,728.6. WiseTech Global dropped 3.18% after the antitrust regulator raised concerns over an acquisition and planned divestment. The Australian dollar traded at 66.75 U.S. cents. Investors await Australia’s November CPI on Wednesday and the U.S. jobs report on Jan. 9.
5 January 2026
···········
NexGen Energy stock jumps 11%: the next dates that matter for NXE

NexGen Energy stock jumps 11%: the next dates that matter for NXE

NexGen Energy’s U.S. shares jumped 11.4% to $10.25 Friday, with volume tripling to 13.1 million after Denison Mines announced readiness to launch its Phoenix uranium project. The rally pushed NexGen to a 52-week high. Attention now shifts to a January 9 intervention deadline and a February licensing hearing for NexGen’s Rook I project before Canadian regulators.
4 January 2026
·
NexGen Energy stock jumps as uranium names rally on Canada project milestone

NexGen Energy stock jumps as uranium names rally on Canada project milestone

NexGen Energy shares jumped 9.8% to $10.10 in New York midday trading Friday, following Denison Mines’ announcement it is ready to start building its Phoenix uranium project. Uranium-linked stocks outperformed after Denison updated its Phoenix capital cost estimate to $600 million. NexGen’s next regulatory hearing is set for February. Uranium futures traded near $81.65 per pound.
2 January 2026
···
NexGen Energy Stock (NXE) News and Forecast for Dec. 23, 2025: Final Rook I Hearings Loom as Analysts Stay Bullish

NexGen Energy Stock (NXE) News and Forecast for Dec. 23, 2025: Final Rook I Hearings Loom as Analysts Stay Bullish

NexGen Energy shares traded at C$13.03 on the TSX and around US$9.44 on the NYSE on Dec. 23, 2025. The Canadian Nuclear Safety Commission will hold the final hearing for NexGen’s Rook I uranium project on Feb. 9–13, 2026, after which a decision is expected. The project’s federal environmental review advanced in January 2025 when CNSC staff accepted NexGen’s final Environmental Impact Statement.
23 December 2025
·····
Australian Stock Market Weekly Wrap: ASX 200 Edges Higher Amid ASX Outage, Strong GDP and Rate-Hike Jitters (1–6 December 2025)

Australian Stock Market Weekly Wrap: ASX 200 Edges Higher Amid ASX Outage, Strong GDP and Rate-Hike Jitters (1–6 December 2025)

The S&P/ASX 200 ended the first week of December slightly higher at 8,634.6, recovering from a 0.6% drop after a major ASX outage on Monday. September-quarter GDP rose 2.1% year-on-year, fueling rate hike speculation. October inflation held at 3.8%. Lithium miners and data-centre operator NextDC outperformed.
6 December 2025
·····

Stock Market Today

  • Big Tech Stocks Fuel Surge in Trump’s Trading Activity
    May 19, 2026, 6:05 AM EDT. President Trump's trading activity surged more than tenfold in the first quarter, driven by significant investments in Big Tech stocks including Nvidia and Dell. His money managers executed over 3,700 trades, marking a sharp increase compared to previous periods. The focus on major technology companies reflects a strategic shift from his earlier real estate ventures to high-value tech equities. This volume of trades indicates heightened market engagement and possibly a repositioning of his portfolio amid evolving market conditions.

Latest articles

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.
Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

19 May 2026
Alphabet shares rose in pre-market trading Tuesday after Google and Blackstone announced a U.S. AI cloud venture, with Blackstone committing $5 billion to add 500 megawatts of data-center capacity by 2027. Alphabet’s Class A shares closed Monday at $396.94 and were quoted at $401.09 before the market opened. The move coincides with the first day of Google I/O and follows strong Q1 earnings.

Popular

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.
Go toTop